Clinical Trial Update: OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry Eye [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of OTX-DP for the treatment of dry eye has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• OTX-DP

Snippet

Sponsor: Ocular Therapeutix, Inc. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2018-03-29